Pure Global AI
ANVISA registration 81552290015Valid until Apr 15, 2034

ANTIBODY FOR HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 AND TYPE 2 (HIV 1 AND HIV 2)

ANVISA Registration Number: 81552290015SETTY ASSESSORIA E CONSULTORIA EM ASSUNTOS REGULATORIOS LTDAQINGDAO HIGHTOP BIOTECH CO.,LTD.Risk Class IV
Device names
Technical name
ANTIBODY FOR HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 AND TYPE 2 (HIV 1 AND HIV 2)
PT: ANTICORPO PARA VÍRUS DE IMUNODEFICIÊNCIA HUMANA TIPO 1 E TIPO 2 (HIV 1 E HIV 2)
Commercial name
Família Teste Rápido de Anticorpo HIV 1/2
Risk class
Class IV
Registration details
Registration Number
81552290015
Process Number
25351334159202371
CNPJ
26406496000191
Company information
Manufacturing Country
China
PT: CHINA, REPÚBLICA POPULAR
Dates and status
Publication Date
Apr 15, 2024
Validity
15/04/2034
Last Updated
08/18/2026 19:00:00
About this record

Access comprehensive regulatory information for ANTIBODY FOR HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 AND TYPE 2 (HIV 1 AND HIV 2) in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 81552290015 and manufactured by QINGDAO HIGHTOP BIOTECH CO.,LTD.. The registration is held by SETTY ASSESSORIA E CONSULTORIA EM ASSUNTOS REGULATORIOS LTDA with validity until Apr 15, 2034.

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.